FDA advisers support approval of RSV vaccine to protect infants Enlarge this image toggle caption Kateryna Kon/Getty Images/Science Photo Library Kateryna Kon/Getty Images/Science Photo Library Advisers to the Food and Drug Administration recommended that the agency should approve the first vaccine to protect infants from RSV, or respiratory syncytial virus. In a two-part vote, the experts voted unanimously, 14-0, that …